Cargando…
Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome
Fluoxetine is used as a therapeutic agent for autism spectrum disorder (ASD), including Fragile X syndrome (FXS). The treatment often associates with disruptive behaviors such as agitation and disinhibited behaviors in FXS. To identify mechanisms that increase the risk to poor treatment outcome, we...
Autores principales: | Uutela, Marko, Lindholm, Jesse, Rantamäki, Tomi, Umemori, Juzoh, Hunter, Kerri, Võikar, Vootele, Castrén, Maija L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036306/ https://www.ncbi.nlm.nih.gov/pubmed/24904293 http://dx.doi.org/10.3389/fncel.2014.00150 |
Ejemplares similares
-
Repeated brief isoflurane anesthesia during early postnatal development produces negligible changes on adult behavior in male mice
por: Rosenholm, Marko, et al.
Publicado: (2017) -
Activation of TrkB in Parvalbumin interneurons is required for the promotion of reversal learning in spatial and fear memory by antidepressants
por: Jetsonen, Elias, et al.
Publicado: (2023) -
An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis
por: Talvio, Karo, et al.
Publicado: (2023) -
Effects of PSA Removal from NCAM on the Critical Period Plasticity Triggered by the Antidepressant Fluoxetine in the Visual Cortex
por: Guirado, Ramon, et al.
Publicado: (2016) -
ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem
por: Morello, Francesca, et al.
Publicado: (2020)